3.67 USD
▼-0.22-5.66%
盘后 3.73 +1.63%
2026-09-15
市值
$254.77M
市盈率
—
EPS
-2.74
股息率
—
52 周区间
3.65 – 9.16
成交量
544.65K
Beta
1.54
目标价
9.50
52W 低 3.6552W 高 9.16
价格走势
公司简介
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company’s products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing tumor; BT7480, a Bicycle tumor-targeted imm...